Lembas
PrivateLast Round
Pre Seed
Jun 11, 2025
Total Funding Raised
$3.6M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Lembas operates in Healthcare & Life Sciences and is based in Tel Aviv. Its latest recorded funding round was a Pre Seed round in June 2025.
Lembas is a biotechnology company that has developed an AI-powered discovery platform to create bioactive ingredients for functional foods and supplements, with a first product aimed at appetite regulation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lembas Comparables
Compare Lembas with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nuritas | 75% | |
| Zero Cow Factory | 71% | |
| Brightseed | 66% |
For institutional investors. Book with your work email.
Lembas Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lembas Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fresh.Fund | Pre Seed |
| FLORA Ventures | Pre Seed |
| SDH Ventures | Pre Seed |
| Maia Ventures | Pre Seed |
| Longevity Venture Partners | Pre Seed |
| Bluestein Ventures | Pre Seed |
| Mandi Ventures | Pre Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 943% MoM, reaching 2.1K.
- May 19, 2026
Monthly visitors increased 1545% MoM, reaching 2.4K.
For institutional investors. Book with your work email.
Lembas Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lembas's valuation, stock price, and market status.
Is Lembas a public or private company?
Lembas is a private company.
What is the current stock price of Lembas?
Lembas is a private company, so its shares have no public market price. Caplight tracks Lembas's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lembas worth (valuation)?
Valuation information for Lembas is not publicly available.
Can I buy Lembas stock?
Lembas shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lembas's last funding round?
Lembas's most recent funding round was Pre Seed on June 11, 2025.
Who are the main investors in Lembas?
Key investors in Lembas include FLORA Ventures.
Will Lembas IPO soon?
No public IPO plans have been announced for Lembas.
How can I track Lembas secondary market activity?
Caplight tracks bids, offers, and trades in Lembas's shares on secondary markets.